Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

12FJ

Crystal structure of 6-fluoropyrazolo[1,5-a]pyridine derivative bound to KIT

This is a non-PDB format compatible entry.
Summary for 12FJ
Entry DOI10.2210/pdb12fj/pdb
DescriptorMast/stem cell growth factor receptor Kit, ~{N}-[5-(5-cyclopropyl-4~{H}-1,2,4-triazol-3-yl)-4-fluoranyl-2-methyl-phenyl]-6-fluoranyl-pyrazolo[1,5-a]pyridine-3-carboxamide (2 entities in total)
Functional Keywordskit inhibitor, tyrosine kinase inhibitor, inflammation, allergy, chronic urticaria, transferase
Biological sourceHomo sapiens (human)
More
Total number of polymer chains1
Total formula weight38954.96
Authors
Walker, N.P.,Jeffrey, J.L.,Blaesse, M. (deposition date: 2026-04-02, release date: 2026-08-05)
Primary citationChen, K.Y.,Qu, S.,Yan, X.,Moon, H.,Lamani, M.,Wang, Z.,Mata, G.,Zhu, J.,Schweickert, P.G.,Sivick, K.E.,Huang, H.T.,Van Abbema, A.M.,Zhao, X.,Green, D.W.,Jin, L.,Young, S.W.,Walters, M.J.,Walker, N.P.,Leleti, M.R.,Powers, J.P.,Jeffrey, J.L.
Discovery of a Potent, Orally Bioavailable Small-Molecule Inhibitor of Wildtype KIT with Exceptionally High Kinome Selectivity.
J.Med.Chem., 2026
Cited by
PubMed Abstract: Mast cells play critical roles in the pathogenesis of many allergic and inflammatory diseases. KIT, a receptor tyrosine kinase, is a crucial regulator of mast cells and, in consequence, the modulation of mast cells through KIT inhibition presents a promising therapeutic approach for treating a range of chronic diseases. Clinical applications of small-molecule KIT inhibitors have been limited to oncology due to adverse effects associated with poor kinome selectivity. Here, we describe a highly selective small-molecule KIT inhibitor () that exhibits excellent broad kinome selectivity, with a selectivity score of S(50%) = 0.003. Data-driven investigations of structure-activity relationships and careful modulation of physicochemical properties yielded improvements in potency, selectivity, and metabolic stability. Compound demonstrated promising therapeutic efficacy in an SCF-driven acute cutaneous anaphylaxis model in rodents.
PubMed: 42503832
DOI: 10.1021/acs.jmedchem.6c00898
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.629 Å)
Structure validation

258009

PDB entries from 2026-08-12

PDB statisticsPDBj update infoContact PDBjnumon